Peer Review History: Glutathione an Effective Adjuvant Therapy for Acute Respiratory Distress Syndrome Associated with COVID-19 Infection

Editor(s):

(1) Dr. Chan-Min Liu, School of Life Science, Xuzhou Normal University, Xuzhou City, China.

(2) Dr. Masahiro Hasegawa, Mie University Graduate School of Medicine, Japan.

Reviewers:

(1) Mohamed Fahmy Azooz, Egypt.

(2) Youssef Mir, University Ibn Zohr, Morocco.

(3) Shaharior Rahman Razu, Khulna University, Bangladesh.

(4) Abu Md Ashif Ikbal, Tripura University, India.

(5) Mohammed Nader Shalaby, Suez Canal University, Egypt.

Additional Reviewers:

(1) Dai Dinh, Hanoi University of Pharmacy, Vietnam.

(2) Priyanka. A, Shri Atal Bihari Vajpayee Medical College and Research Institute, India.

(3) Sahar Elderdiri Gafar Osman, Al-Fajr College for Science and Technology, Sudan.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.6/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Mohamed Fahmy Azooz, Egypt) | File 1 | File 2


Stage 2 | Peer review report_2 (Youssef Mir, Morocco) | File 1 | NA


Stage 2 | Peer review report_3 (Shaharior Rahman Razu, Bangladesh) | File 1 | NA


Stage 2 | Peer review report_4 (Abu Md Ashif Ikbal, India) | File 1 | NA


Stage 2 | Peer review report_5 (Mohammed Nader Shalaby, Egypt) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.